Recursion Q4 Loss Narrows to $0.21, Revenue Hits $35.5M, Shares Jump 11%
Recursion narrowed its Q4 non-GAAP loss to $0.21 per share versus an expected $0.27 and delivered revenue of $35.54 million against forecasts of $24.59 million, triggering an 11% jump in shares. The rally lifted the stock above its 20-day moving average, though longer-term SMAs remain 16–19% lower.
1. Q4 Earnings Outperformance
Recursion reported a non-GAAP loss per share of $0.21 in Q4, outperforming the $0.27 loss analysts anticipated, while revenue reached $35.54 million, comfortably above the $24.59 million consensus. CEO Najat Khan described this as an inflection point, highlighting the transition from AI validation to generating clinical proof and durable value.
2. Market Reaction and Technical Indicators
Shares rallied roughly 11%, pushing the stock 2.1% above its 20-day simple moving average despite remaining 16.1% and 19.4% below the 100-day and 200-day averages. The RSI held at 38.97, signaling neutral momentum, while the MACD line at -0.2576 sat below its signal line at -0.2369, indicating lingering bearish pressure.